SEC Form 4 · accession 0001415889-17-000306
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $3.00 | Feb 17, 2017 | P | 60,000 | A | Feb 17, 2017 | Feb 22, 2017 | Common Stock | 60,000 | 60,000 | D |
| WarrantsF1 | $3.00 | Feb 17, 2017 | P | 19,179 | A | Feb 17, 2017 | Feb 22, 2017 | Common Stock | 19,179 | 79,179 | D |
Explanation of responses
- F1The warrants purchased trade publicly under the symbol "MDVXW" on the NASDAQ Stock Market.